UTHR — UNITED THERAPEUTICS CORP DEL

Ownership history in Ruffer LLP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Ruffer LLP reported a position in UNITED THERAPEUTICS CORP DEL (UTHR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.13% (2025 Q3)
Avg. % of fund
0.4%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 48,545 +37,782 +351.0% 1.13% $20.3M $419.21
2025 Q2 REDUCED 10,763 -3,611 -25.1% 0.14% $3.1M $287.35
2025 Q1 ADDED 14,374 +2,925 +25.5% 0.17% $4.4M $308.27
2024 Q4 INITIATED 11,449 — — 0.15% $4.0M $352.84
% of Fund (quarterly)    UTHR price (monthly, adj. close)

Other funds also holding UTHR

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.71% Avoro Capital Advisors LLC 3Y 7Y 12.48% Tri Locum Partners LP 3Y 7.65% Nepsis Inc. 3Y 7Y 6.59% Eversept Partners, LP 3Y 7Y 6.2% Summit Street Capital Management, LLC 3Y 7Y 4.36% Polaris Capital Management, LLC 3Y 7Y 4.19% Nitorum Capital, L.P. 3Y 7Y 3.99% Palo Alto Investors LP 3Y 7Y 3.95% First Turn Management, LLC 3.54%
← Back to Ruffer LLP Holdings